Salvus Health, a Belgian startup focused on enhancing pharmacy operations, has secured €500,000 in funding to expand its smart service platform and improve patient services.
Information on the Target
Salvus Health is an innovative Belgian startup that specializes in providing a smart service platform aimed at enhancing the productivity and efficiency of pharmacists. This platform automates routine tasks such as appointment scheduling and patient reminders, allowing pharmacists to concentrate more on their advisory roles. Co-founder Philip Van den Bergh highlights the substantial workload pharmacists face, especially when they are expected to perform additional services such as vaccinations while managing their existing responsibilities. The platform also includes an integrated customer relationship management (CRM) system designed to facilitate better communication with patients, thereby improving patient care and service delivery.
Industry Overview in Belgium
The pharmaceutical sector in Belgium is renowned for its high-quality healthcare services and well-trained professionals. The industry plays a vital role in patient care, particularly in the context of an aging population that requires more frequent medical assistance. Pharmacists are increasingly being recognized as essential players within this healthcare landscape, particularly as governments begin to reimburse services such as vaccinations and medical consultations. However, despite these advancements, many pharmacists in Belgium are still struggling with outdated systems that hinder their ability to provide comprehensive patient care.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Furthermore, the Belgian healthcare system acknowledges the strategic importance of utilizing pharmacists to alleviate pressures on other healthcare providers. This is especially crucial in the post-pandemic e
Similar Deals
Bioqube Ventures, Flanders Future Tech Fund, Qbic → Spica Therapeutics
2025
BAN Flanders, BeAngels, NXT-2, LRM, Qbic → Innocens
2025
LUMO Labs, Heran Partners, imec.istart future fund → Nuclivision
2025
Bioqube Ventures and Flanders Future Tech Fund (FFTF) → Spica Therapeutics
2025
Seeder Fund, LRM and private investors → Monsana
2024
Novo Nordisk A/S and BioGeneration Ventures → Tanai Therapeutics
2024
Angelwise
invested in
Salvus Health
in 2025
in a Seed Stage deal
Disclosed details
Transaction Size: $1M